Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New brain scan study aims to sharpen diagnosis of Parkinson's and dementia

NCT ID NCT06083467

First seen Jan 08, 2026 · Last updated Jun 20, 2026 · Updated 28 times

Summary

This study is testing whether new brain imaging techniques can better diagnose diseases like Parkinson's, multiple system atrophy, and frontotemporal dementia. Researchers will use MRI scans and neurological exams in about 94 adults aged 40-85. The goal is to improve how doctors identify these conditions, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to more accurate diagnosis of neurodegenerative diseases like Parkinson's and dementia using brain imaging.

What could go wrong

This is an early-stage observational study, not a treatment trial. It may not directly improve patient outcomes or lead to new therapies.

Conditions

The condition(s) this trial relates to.

frontotemporal dementia movement disorder multiple system atrophy Parkinson disease progressive supranuclear palsy tauopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.